0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Clinical Trials Update | 
Anita Slomski, MA
JAMA. 2016;315(20):2159. doi:10.1001/jama.2016.5372.

Clinical Trials Update | 
Anita Slomski, MA
JAMA. 2016;315(20):2159. doi:10.1001/jama.2016.6212.

Original Investigation | 
Katherine T. Mills, PhD; Jing Chen, MD; Wei Yang, PhD; et al.
JAMA. 2016;315(20):2200-2210. doi:10.1001/jama.2016.4447.
Includes: CME, Supplemental Content

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2016;315(13):1327. doi:10.1001/jama.2016.3236.

Original Investigation | 
Ida Behrens, MD; Saima Basit, MSc; Jacob Alexander Lykke, MD, DMSc; et al.
JAMA. 2016;315(10):1026-1033. doi:10.1001/jama.2016.1869.
Includes: Supplemental Content

Original Investigation | 
Sudhakar V. Nuti, BA; Li Qin, PhD; John S. Rumsfeld, MD; et al.
JAMA. 2016;315(6):582-592. doi:10.1001/jama.2016.0278.
Includes: Supplemental Content

JAMA Diagnostic Test Interpretation | 
Biff F. Palmer, MD; Deborah J. Clegg, PhD
JAMA. 2015;314(22):2405-2406. doi:10.1001/jama.2015.9230.

Original Investigation |  FREE
Mihai Gheorghiade, MD; Stephen J. Greene, MD; Javed Butler, MD, MPH, MBA; et al.
JAMA. 2015;314(21):2251-2262. doi:10.1001/jama.2015.15734.
Includes: Supplemental Content

Research Letter |  FREE
Lauren B. Cooper, MD; Bradley G. Hammill, DrPH; Eric D. Peterson, MD, MPH; et al.
JAMA. 2015;314(18):1973-1975. doi:10.1001/jama.2015.11904.

Original Investigation |  FREE
Evrim B. Turkbey, MD; Marcelo S. Nacif, MD, PhD; Mengye Guo, PhD; et al.
JAMA. 2015;314(18):1945-1954. doi:10.1001/jama.2015.14849.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Cardiac Protection in HER2-Targeted Treatment How Should We Measure New Strategies?
Ana Barac, MD, PhD; Sandra M. Swain, MD
JAMA Cardiology
Brief Report  | 
Potential Mortality Reduction With Optimal Implementation of Angiotensin Receptor Neprilysin Inhibitor Therapy in Heart Failure
Gregg C. Fonarow, MD; Adrian F. Hernandez, MD, MHS; Scott D. Solomon, MD; et al.
JAMA Cardiology
Original Investigation  | 
Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction
Thomas A. Gaziano, MD, MSc; Gregg C. Fonarow, MD; Brian Claggett, PhD; et al.
JAMA Oncology
Original Investigation  | 
Trastuzumab-Related Cardiotoxic Effects in Taiwanese Women A Nationwide Cohort Study
Hsu-Chih Chien, MS; Yea-Huei Kao Yang, BSPharm; Jane P. F. Bai, AM, PhD